Page 5 - Phasei Ii News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A leader from the global research services company shares how in-home services maximize patient convenience and COVID-19's impact on clinical studies.

A leader from Praxis explains how the firm worked with Moderna on patient recruitment strategy and other solutions in the road to launching a vaccine. Tricia Barrett, senior vice president and managing director for Praxis, is one of the two presenters (the other Diane Montross, senior director of patient recruitment and retention at Moderna) for Operation Warp Speed: Recruitment and Retention, Launching a Recruitment Strategy for a Phase III COVID-19 Vaccine Trial, taking place online Tuesday, March 2 at 2:20 pm EST. She shared how the partnership between the two c...

The federal agency continues to keep researchers, pharma firms and citizens apprised of current happenings and research related to the virus and pandemic.

Calyx spins off medical imaging, eClinical solutions firm Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward. Calyx—a UK-based company offering medical imaging, eClinical and regulatory services to clinical research clients—has shed the name Parexel Informatics in favor of its new moniker. After this strategic separation, the company will continue its work pursuing innovative technology intended to accelerate the discovery and development of new treatments. With ...

Pfizer pours $25m into Vedanta's Phase II IBD study The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciences’ VE202 inflammatory bowel disease treatment candidate. PureTech Health, a clinical-stage biotherapeutics firm, has announced its Vedanta Biosciences founded entity has landed a $25m (20.6 EUR) investment as part of the Pfizer Breakthrough Growth Initiative (PGBI). Vedanta plans to use the money to fund its Phase II study of VE202 to treat inflammatory bowel disease (IBD), scheduled to launch in 2021. A Vedanta spok...